Abstract
Phase 1b/2 Study of the Efficacy and Safety of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have